GCP
NERV icon

GSA Capital Partners’s Minerva Neurosciences NERV Stock Holding History

GSA Capital Partners’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-60,079
Closed -$836K – 1661
2021
Q3 		$836K Buy
60,079
+12,393
+26% +$186K 0.09% 395
2021
Q2 		$885K Buy
47,686
+31,102
+188% +$669K 0.1% 310
2021
Q1 		$387K Buy
16,584
+2,083
+14% +$52K 0.06% 488
2020
Q4 		$271K Buy
+14,501
New +$365K 0.04% 799
2020
Q2 		– Sell
-1,260
Closed -$61K – 939
2020
Q1 		$61K Sell
1,260
-5,607
-82% -$338K 0.02% 945
2019
Q4 		$391K Buy
+6,867
New +$303K 0.05% 832
2019
Q3 		– Sell
-6,020
Closed -$271K – 1600
2019
Q2 		$271K Sell
6,020
-2,943
-33% -$147K 0.03% 1067
2019
Q1 		$564K Sell
8,963
-712
-7% -$42.8K 0.06% 623
2018
Q4 		$522K Buy
9,675
+1,400
+17% +$102K 0.06% 539
2018
Q3 		$831K Buy
+8,275
New +$622K 0.05% 790
2017
Q4 		– Sell
-2,000
Closed -$122K – 1729
2017
Q3 		$122K Sell
2,000
-5,325
-73% -$305K 0.01% 1503
2017
Q2 		$519K Buy
7,325
+2,375
+48% +$154K 0.03% 989
2017
Q1 		$321K Buy
+4,950
New +$384K 0.02% 1342

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

GSA Capital Partners's NERV Position: Q4 2021 in Review

GSA Capital Partners sold out of Minerva Neurosciences (NERV) in Q4 2021, closing a stake of 60,079 shares — an estimated $836K sold.

GSA Capital Partners first reported a position in NERV in Q1 2017 and held it in 13 quarters. The position peaked at $885K in Q2 2021. 35 funds tracked by Wall St. Rank hold NERV as of Q4 2021.

  • GSA Capital Partners reported no remaining Minerva Neurosciences position as of Q4 2021 after selling out during the quarter.
  • GSA Capital Partners sold 60,079 Minerva Neurosciences shares in Q4 2021, an estimated $836K.
  • GSA Capital Partners first reported a position in Minerva Neurosciences in Q1 2017 and held it in 13 quarters.
  • GSA Capital Partners's Minerva Neurosciences position peaked at $885K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2021.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.